Catalent Launches OptiForm Solution Suite for Accelerated Drug Development at CPhI Worldwide 2015

Catalent Pharma Solutions is launching its new OptiForm Solution Suite platform at CPhI Worldwide 2015. The platform, which combines four technologies, including advanced parallel screening, is designed to match the most suitable drug delivery technologies to the API with the goal of providing optimal candidate formulations for animal pharmacokinetic studies in 12 weeks.

OptiForm Solution Suite aims to enhance drug bioavailability and to accelerate more molecules to the clinic and beyond.

Catalent is also showcasing several other advanced development and manufacturing technologies during the show, highlighting its tech transfer capabilities and flexible manufacturing solutions, including custom manufacturing suites, and the ability to handle cytotoxic and highly potent APIs. The company will detail how it has successfully combined these facilities and expertise to launch 175 new products to the market in 2014.

Catalent executives will be speaking at the Exhibitor Showcase:

• Tuesday, 13 October, 2.30 pm-Flexible Manufacturing Solutions: From Special Handling to Custom Suites, by Michael Valazza, vice president, Global Business Development, Advanced Delivery Technologies.

• Wednesday, 14 October, 11.30 am-Mitigating the Risk of Aseptic Filling with an Automated Advanced Aseptic Process for Glass-Free Injectable Vials, by Bill Hartzel, director, Strategic Execution, Advanced Delivery Technologies.

Catalent is also participating in two Pharma Insight Briefings during the show:

• Tuesday, 13 October, 12.00 pm-Latest Trends in Animal Health, Using Advanced Human Technologies to Deliver Breakthrough Improvements in Product Delivery, by Dan Peizer, director of Global Sales and Marketing, Animal Health.

• Tuesday, 13 October, 1.00 pm- Softgel as an Innovative, Flexible Delivery Form with More Consumer Preferred Benefits, by Claudia Valla, product development adviser.

Source: Catalent, Booth 3G10